Reducing the serotonin deficit caused by a breakdown in the passage of serotonin molecules from the presynaptic cell to receptors on the postsynaptic cell has been identified as a successful treatment for clinical depression for many individuals. A new series of drugs, Selective Serotonin Reuptake Inhibitors, prevent the presynaptic cell from re-uptaking serotonin, thereby allowing normal amounts of serotonin to reach the receptors on the postsynaptic cell.

Which of the following can be correctly inferred from the above statements?

A. If too much serotonin is released to the receptors, a person will feel extremely euphoric.
B. Taking a Selective Serotonin Reuptake Inhibitor is currently the only successful treatment for clinical depression.
C. Individuals who have normal levels of serotonin uptake do not run the risk of suffering from depression.
D. By not taking a Selective Serotonin Reuptake Inhibitor, individuals with depression run the risk of depleting their serotonin levels.
E. Taking Selective Serotonin Reuptake Inhibitors reduces the incidence of depression in some people.